Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 6Neoplasms 4Colonic Neoplasms 3Prostatic Neoplasms 2Patient Satisfaction 2Ovarian Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Tuberculosis, Pulmonary 1Thoracic Diseases 1Supratentorial Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Polyps 1Pituitary Neoplasms 1Pain, Postoperative 1Pain 1Overweight 1Obesity 1Neurofibromatoses 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Mouth Neoplasms 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hypoxia 1

Interventions

Morphine 2dexketoprofen trometamol 1Saline Solution 1Ropivacaine 1Remifentanil 1Propofol 1Lidocaine 1Epinephrine 1Dexmedetomidine 1Dexamethasone 1Analgesics, Opioid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Supratentorial Neoplasms × Propofol × Clear all
NCT02593942 2015-11-02

Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy

Yeditepe University Hospital

Phase 4 Completed
80 enrolled

Supratentorial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡